National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

852A
A synthetic imidazoquinoline Toll-like receptor 7 (TLR7) agonist with immunostimulating and potential antitumor activities. TLR7 agonist 852A binds to and activates TLR7, thereby stimulating plasmacytoid dendritic cells (pDC) through the TLR7-MyD88-dependent signaling pathway. Activation of pDC results in secretion of interferon alpha, the production of proimflammatory cytokines, the upregulation of co-stimulatory molecules, and enhanced T and B-cell stimulatory responses. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:TLR7 agonist 852A
Toll-like receptor agonist 852A



Previous:6-azauridine, 7-cyanoquinocarcinol, 7-hydroxystaurosporine, 8-hydroxyquinoline sulfate ointment, 851B gel
Next:99mTc-DTPA-mannosyl-dextran, [18F]-labeled substance P antagonist receptor quantifier, [18F]-ML-10, [F-18]HX4, abagovomab

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov